A Sustainable Investment in Journalism

A sustainable business requires diverse revenue streams. ESG Investor now operates a subscription service as of Tuesday 14th May. To find out more please get in touch with our subscription team on subscriptions@esginvestor.net

Industry

Further Pressure on Pharma Needed to Tackle AMR Risks

Investors urged to flag financial and systemic risks of anti-microbial resistance and to support collaborative engagement initiatives to ensure influence on policy.

Investor concerns over anti-microbial resistance (AMR) have encouraged use of more responsible practices by pharmaceuticals firms, according to a new report, but the authors say increased engagement can accelerate their adoption. Published last week by the Access to Medicine Foundation (AMF), ‘Methods Matter’ outlined recent progress by firms involved in…

To continue reading...


Subscribe

Subscribe to ESG Investor to gain access to the leading platform for news, analysis, and interviews across sustainable investing. Select subscribe below to view our subscription packages or you can email us at subscriptions@esginvestor.net to discuss your options.

Subscribe

Request a Trial

Get in touch today to discuss a trial giving you unrestricted and unlimited access to ESG Investor for you and/or your team(s) for a limited period. Email us at subscriptions@esginvestor.net

The practical information hub for asset owners looking to invest successfully and sustainably for the long term. As best practice evolves, we will share the news, insights and data to guide asset owners on their individual journey to ESG integration.

Copyright © 2024 ESG Investor Ltd. Company No. 12893343. ESG Investor Ltd, Fox Court, 14 Grays Inn Road, London, WC1X 8HN

To Top
Share via
Copy link
Powered by Social Snap